New FDA Approvals

Name: Relias Media
Price range: $

October 1, 2000

Issue Date: October 1, 2000

Table of Contents

Mission possible: Making the Internet safe for private patient information
With Lotronex, a guide is part of the package
Fear of terrorists leads to new indication for Cipro
Aerosol cyclosporine hits the target
New stops mapped on the genomic road
Expiration dating changes for lithium carbonate
Searle sends a warning about misoprostol use
New FDA Approvals
In the PIPELINE
Equivalence codes
Meloxicam (Mobic) for relief of osteoarthritis symptoms
Doxercalciferol (Hectorol) for patients undergoing renal dialysis

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

AR@relias.com

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com